Translational Findings Support Regimen Selection for First-in-human Study of Ubamatamab (MUC16 X CD3 Bispecific Antibody) in Patients with Recurrent Ovarian Cancer
CTS-CLINICAL AND TRANSLATIONAL SCIENCE（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined